$CYDY
CytoDyn Inc.

2014 Q2 Form 10-K Financial Statement

#000119312514265518 Filed on July 10, 2014

View on sec.gov

Income Statement

Concept 2014 Q2 2014 2013 Q2
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $950.0K $3.780M $1.330M
YoY Change -28.57% -47.13% -59.33%
% of Gross Profit
Research & Development $1.590M $3.981M $370.0K
YoY Change 329.73% 542.34% 208.33%
% of Gross Profit
Depreciation & Amortization $90.00K $350.0K $220.0K
YoY Change -59.09% 59.09%
% of Gross Profit
Operating Expenses $2.640M $8.113M $1.910M
YoY Change 38.22% 1.49% -43.66%
Operating Profit -$8.113M
YoY Change 1.49%
Interest Expense -$430.0K $4.510M -$940.0K
YoY Change -54.26% 131.44%
% of Operating Profit
Other Income/Expense, Net $70.00K $180.0K $370.0K
YoY Change -81.08% -51.35%
Pretax Income -$3.000M -$12.43M -$2.490M
YoY Change 20.48% 29.92% -26.55%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$3.000M -$12.43M -$2.490M
YoY Change 20.48% 29.92% -26.55%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$53.34K -$265.0K -$80.95K
COMMON SHARES
Basic Shares Outstanding 55.75M shares 30.89M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q2 2014 2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.890M $4.890M $600.0K
YoY Change 715.0% 715.0% 114.29%
Cash & Equivalents $4.886M $603.7K
Short-Term Investments
Other Short-Term Assets $560.0K $560.0K $240.0K
YoY Change 133.33% 133.33% -68.0%
Inventory
Prepaid Expenses $488.8K $139.8K
Receivables
Other Receivables
Total Short-Term Assets $5.443M $5.440M $840.5K
YoY Change 547.65% 547.62% -18.27%
LONG-TERM ASSETS
Property, Plant & Equipment $16.80K $20.00K $0.00
YoY Change -100.0%
Goodwill
YoY Change
Intangibles $2.967M $3.317M
YoY Change -10.55% 8491.66%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $2.984M $2.990M $3.317M
YoY Change -10.04% -9.94% 7698.85%
TOTAL ASSETS
Total Short-Term Assets $5.443M $5.440M $840.5K
Total Long-Term Assets $2.984M $2.990M $3.317M
Total Assets $8.427M $8.430M $4.158M
YoY Change 102.69% 102.64% 288.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.287M $1.290M $1.111M
YoY Change 15.79% 16.22% 33.67%
Accrued Expenses $65.00K $500.0K $321.9K
YoY Change -79.81% -32.43% 113.77%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $330.0K
YoY Change -100.0% -100.0%
Long-Term Debt Due $328.3K
YoY Change
Total Short-Term Liabilities $2.166M $2.170M $3.229M
YoY Change -32.9% -32.82% -35.99%
LONG-TERM LIABILITIES
Long-Term Debt $2.339M $2.340M $1.153M
YoY Change 102.83% 103.48%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $2.339M $2.340M $1.153M
YoY Change 102.83% 103.48%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.166M $2.170M $3.229M
Total Long-Term Liabilities $2.339M $2.340M $1.153M
Total Liabilities $4.505M $4.510M $4.382M
YoY Change 2.82% 2.97% -13.14%
SHAREHOLDERS EQUITY
Retained Earnings -$46.43M -$34.00M
YoY Change 36.56%
Common Stock $30.37M $16.14M
YoY Change 88.1% 6.56%
Preferred Stock
YoY Change
Treasury Stock (at cost) $100.0K
YoY Change 0.0%
Treasury Stock Shares 200.0K shares
Shareholders Equity $3.922M $3.920M -$223.9K
YoY Change
Total Liabilities & Shareholders Equity $8.427M $8.430M $4.158M
YoY Change 102.69% 102.64% 288.27%

Cashflow Statement

Concept 2014 Q2 2014 2013 Q2
OPERATING ACTIVITIES
Net Income -$3.000M -$12.43M -$2.490M
YoY Change 20.48% 29.92% -26.55%
Depreciation, Depletion And Amortization $90.00K $350.0K $220.0K
YoY Change -59.09% 59.09%
Cash From Operating Activities -$1.750M -$7.387M -$990.0K
YoY Change 76.77% 117.72% -34.44%
INVESTING ACTIVITIES
Capital Expenditures -$10.00K $19.22K $0.00
YoY Change 513.08%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$10.00K -$19.22K $0.00
YoY Change -99.45%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $13.64M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -750.0K 11.69M 1.180M
YoY Change -163.56% 62.03% 11700.0%
NET CHANGE
Cash From Operating Activities -1.750M -7.387M -990.0K
Cash From Investing Activities -10.00K -19.22K 0.000
Cash From Financing Activities -750.0K 11.69M 1.180M
Net Change In Cash -2.510M -7.406M 190.0K
YoY Change -1421.05% -2423.94% -112.67%
FREE CASH FLOW
Cash From Operating Activities -$1.750M -$7.387M -$990.0K
Capital Expenditures -$10.00K $19.22K $0.00
Free Cash Flow -$1.740M -$7.406M -$990.0K
YoY Change 75.76% 118.08% -34.44%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q4 dei Entity Public Float
EntityPublicFloat
67262130
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.60
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10327664 shares
CY2012Q2 us-gaap Stockholders Equity
StockholdersEquity
-3973434
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
284991
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2308279
CY2013Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
30908292 shares
CY2013Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
95100 shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.65
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
18146938 shares
CY2013Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
95100 shares
CY2013Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2013Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2013Q2 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
CY2013Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
30908292 shares
CY2013Q2 us-gaap Interest Payable Current
InterestPayableCurrent
56884
CY2013Q2 us-gaap Deferred Tax Assets Valuation Allowance Noncurrent
DeferredTaxAssetsValuationAllowanceNoncurrent
173000
CY2013Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
328347
CY2013Q2 us-gaap Liabilities Current
LiabilitiesCurrent
3228598
CY2013Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2013Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1153017
CY2013Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
364698
CY2013Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
17778861
CY2013Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1111285
CY2013Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
9680200
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
-223916
CY2013Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-34002819
CY2013Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
6588250
CY2013Q2 us-gaap Preferred Stock Value
PreferredStockValue
274091
CY2013Q2 us-gaap Deferred Tax Liabilities Deferred Expense Deferred Financing Costs
DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts
118100
CY2013Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
321884
CY2013Q2 us-gaap Deferred Tax Liabilities Financing Arrangements
DeferredTaxLiabilitiesFinancingArrangements
1659300
CY2013Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
509000
CY2013Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
1153017
CY2013Q2 us-gaap Long Term Debt
LongTermDebt
1481364
CY2013Q2 us-gaap Liabilities
Liabilities
4381615
CY2013Q2 us-gaap Litigation Reserve Current
LitigationReserveCurrent
536500
CY2013Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
328347
CY2013Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
218750
CY2013Q2 us-gaap Common Stock Value
CommonStockValue
16144673
CY2013Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4157699
CY2013Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
139849
CY2013Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
8256000
CY2013Q2 us-gaap Deferred Offering Costs
DeferredOfferingCosts
96930
CY2013Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2928000
CY2013Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3317239
CY2013Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
291100
CY2013Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
35989
CY2013Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
155500
CY2013Q2 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
CY2013Q2 us-gaap Assets
Assets
4157699
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
603681
CY2013Q2 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
CY2013Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3281250
CY2013Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
386000
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
140321
CY2013Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
4539886
CY2013Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3500000
CY2013Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2013Q2 us-gaap Assets Current
AssetsCurrent
840460
CY2013Q2 cydy Common And Preferred Stock Subject To Rescission
CommonAndPreferredStockSubjectToRescission
536500
CY2013Q2 cydy Common Stock Payable
CommonStockPayable
117778
CY2013Q2 cydy Convertible Notes Face Amount
ConvertibleNotesFaceAmount
6588250
CY2013Q2 cydy Stock Rescission Liability
StockRescissionLiability
536500
CY2014Q2 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.75
CY2014Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55753311 shares
CY2014Q2 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
5.00
CY2014Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
95100 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
29986581 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.13
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
30806361 shares
CY2014Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
95100 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.15
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2014Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2014Q2 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
CY2014Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55753311 shares
CY2014Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
4271250
CY2014Q2 us-gaap Interest Payable Current
InterestPayableCurrent
41276
CY2014Q2 us-gaap Deferred Tax Assets Valuation Allowance Noncurrent
DeferredTaxAssetsValuationAllowanceNoncurrent
159300
CY2014Q2 us-gaap Liabilities Current
LiabilitiesCurrent
2166355
CY2014Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2014Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2338684
CY2014Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
395364
CY2013 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
74492
CY2014Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
20100434
CY2014Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1286715
CY2014Q2 us-gaap Liabilities Subject To Compromise Early Contract Termination Fees
LiabilitiesSubjectToCompromiseEarlyContractTerminationFees
193000
CY2014Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
12363200
CY2014Q2 us-gaap Stockholders Equity
StockholdersEquity
3922232
CY2014Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-46434232
CY2014Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
7221250
CY2014Q2 us-gaap Preferred Stock Value
PreferredStockValue
266251
CY2014Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
65000
CY2014Q2 us-gaap Deferred Tax Liabilities Financing Arrangements
DeferredTaxLiabilitiesFinancingArrangements
663700
CY2014Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
2338684
CY2014Q2 us-gaap Long Term Debt
LongTermDebt
2338684
CY2014Q2 us-gaap Liabilities
Liabilities
4505039
CY2014Q2 us-gaap Litigation Reserve Current
LitigationReserveCurrent
378000
CY2014Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
568750
CY2014Q2 us-gaap Common Stock Value
CommonStockValue
30367779
CY2014Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8427271
CY2014Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
488821
CY2014Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
9957400
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
350000
CY2014Q2 us-gaap Deferred Offering Costs
DeferredOfferingCosts
68292
CY2014Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2893300
CY2014Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2967239
CY2014Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
159300
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
350000
CY2014Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
35989
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
350000
CY2014Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
176200
CY2014Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16797
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
350000
CY2014Q2 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
CY2014Q2 us-gaap Assets
Assets
8427271
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4886122
CY2014Q2 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
CY2014Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2931250
CY2014Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
170042
CY2014Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
4589000
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
177042
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
350000
CY2014Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
1932566
CY2014Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
29000000
CY2014Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3500000
CY2014Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2014Q2 cydy Common And Preferred Stock Subject To Rescission
CommonAndPreferredStockSubjectToRescission
378000
CY2014Q2 cydy Convertible Notes Face Amount
ConvertibleNotesFaceAmount
1200000
CY2014Q2 cydy Stock Rescission Liability
StockRescissionLiability
378000
CY2014Q2 us-gaap Assets Current
AssetsCurrent
5443235
CY2014Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
55753311 shares
CY2014Q2 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
3500000
CY2012Q4 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
3500000
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y10M10D
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.8700 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340 pure
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.61
CY2013 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.000 pure
CY2013 us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0.00 pure
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0070 pure
CY2013 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.32
CY2013 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.391 pure
CY2013 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
29942393 shares
CY2013 us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0028 pure
CY2013 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3392933
CY2013 us-gaap Effective Income Tax Rate Reconciliation Tax Contingencies Other
EffectiveIncomeTaxRateReconciliationTaxContingenciesOther
0.000 pure
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0012 pure
CY2013 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
780000 shares
CY2013 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.051 pure
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
1.73
CY2013 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
18146938 shares
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.26
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
11166274 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
1.0200 pure
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
2567000 shares
CY2013 us-gaap Effective Income Tax Rate Reconciliation Tax Contingencies
EffectiveIncomeTaxRateReconciliationTaxContingencies
0.000 pure
CY2013 us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P2Y
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3135
CY2013 us-gaap Convertible Preferred Dividends Net Of Tax
ConvertiblePreferredDividendsNetOfTax
-2190
CY2013 us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2013 us-gaap Investment Income Interest
InvestmentIncomeInterest
1167
CY2013 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-5744
CY2013 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9570491
CY2013 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
6243502
CY2013 us-gaap Interest Paid
InterestPaid
224724
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-9568301
CY2013 us-gaap Gain Loss On Non Recourse Debt
GainLossOnNonRecourseDebt
372759
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-7993417
CY2013 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
3500000
CY2013 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
73867
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-9568301
CY2013 us-gaap Stock Issued During Period Value Issued For Noncash Considerations
StockIssuedDuringPeriodValueIssuedForNoncashConsiderations
4205
CY2013 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
567000
CY2014 dei Document Type
DocumentType
10-K
CY2013 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
567000
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3261951
CY2013 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
7214758
CY2013 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6204865
CY2013 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1703616
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
3590011
CY2013 us-gaap Depreciation And Amortization
DepreciationAndAmortization
222684
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
318690
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Expected Dividend
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
CY2013 us-gaap Interest Expense Debt
InterestExpenseDebt
245194
CY2013 us-gaap Operating Expenses
OperatingExpenses
7993417
CY2013 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1703616
CY2013 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
6588250
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2013 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
CY2013 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
201000
CY2013 us-gaap Interest Expense
InterestExpense
1948810
CY2013 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1704000
CY2013 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
219000
CY2013 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1128000
CY2013 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3503135
CY2013 us-gaap Legal Fees
LegalFees
946030
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
619838
CY2013 us-gaap Proceeds From Collection Of Longterm Loans To Related Parties
ProceedsFromCollectionOfLongtermLoansToRelatedParties
500000
CY2013 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1099939
CY2013 cydy Common Stock Issued For Services To Consultants Per Share
CommonStockIssuedForServicesToConsultantsPerShare
2.68
CY2013 cydy Common Stock Issued For Series B Preferred Stock
CommonStockIssuedForSeriesBPreferredStock
19000
CY2013 cydy Stock Issued In Payment Of Accounts Payable Per Share
StockIssuedInPaymentOfAccountsPayablePerShare
1.21
CY2013 cydy Preferred And Common Stock Subject To Rescission
PreferredAndCommonStockSubjectToRescission
3212500
CY2013 cydy Amortization Of Prepaid Stock Services
AmortizationOfPrepaidStockServices
160800
CY2013 cydy Amortization Of Deferred Offering Cost Related To Rescission Liability
AmortizationOfDeferredOfferingCostRelatedToRescissionLiability
580392
CY2013 cydy Common Stock Issued Related To Legal Settlement Per Share
CommonStockIssuedRelatedToLegalSettlementPerShare
0.97
CY2013 cydy Original Issue Discount And Intrinsic Value Of Beneficial Conversion Feature Related To Debt
OriginalIssueDiscountAndIntrinsicValueOfBeneficialConversionFeatureRelatedToDebt
6243502
CY2013 cydy Amortization Of Deferred Offering Costs Related To Rescission Liability
AmortizationOfDeferredOfferingCostsRelatedToRescissionLiability
580398
CY2013 cydy Proceeds From Exercise Of Warrants And Stock Options
ProceedsFromExerciseOfWarrantsAndStockOptions
201000
CY2013 cydy Rescission Expirations And Exclusions
RescissionExpirationsAndExclusions
3212500
CY2013 cydy Common Stock Issued On Payment Of Accounts Payable
CommonStockIssuedOnPaymentOfAccountsPayable
80000
CY2013 cydy Stock Issued During Period Value Issued In Payment Of Accounts Payable
StockIssuedDuringPeriodValueIssuedInPaymentOfAccountsPayable
80000
CY2014 dei Trading Symbol
TradingSymbol
CYDY
CY2014 dei Entity Registrant Name
EntityRegistrantName
CYTODYN INC
CY2014 dei Document Period End Date
DocumentPeriodEndDate
2014-05-31
CY2014 dei Entity Central Index Key
EntityCentralIndexKey
0001175680
CY2014 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2014 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--05-31
CY2014 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2014 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2014 dei Amendment Flag
AmendmentFlag
false
CY2014 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2014 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2014 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2014 us-gaap Debt Instrument Maturity Date Range End1
DebtInstrumentMaturityDateRangeEnd1
2016-03-06
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y3M15D
CY2014 us-gaap Preferred Stock Dividend Rate Per Dollar Amount
PreferredStockDividendRatePerDollarAmount
0.25
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.7873 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340 pure
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.74
CY2014 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.096 pure
CY2014 us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0.00 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Tax Contingencies Other
EffectiveIncomeTaxRateReconciliationTaxContingenciesOther
0.000 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0052 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0185 pure
CY2014 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P10Y
CY2014 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
5695000 shares
CY2014 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.27
CY2014 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.248 pure
CY2014 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
46900643 shares
CY2014 us-gaap Debt Instrument Maturity Date Range Start1
DebtInstrumentMaturityDateRangeStart1
2015-10-01
CY2014 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7386943
CY2014 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
50000 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
5704721 shares
CY2014 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> Reclassifications</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> Certain prior year amounts shown in the accompanying consolidated financial statements have been reclassified to conform to the 2014 presentation. These reclassifications did not have any effect on total current assets, total assets, total current liabilities, total liabilities, total shareholders&#x2019; equity (deficit) or net loss.</p> </div>
CY2014 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.004 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
1.49
CY2014 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
30806373 shares
CY2014 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt"> <b>Use of Estimates</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> The preparation of the consolidated financial statements in accordance with accounting principles generally accepted in the United States of America (&#x201C;U.S. GAAP&#x201D;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> </div>
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
18414144 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.9292 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Tax Contingencies
EffectiveIncomeTaxRateReconciliationTaxContingencies
0.000 pure
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y2M16D
CY2014 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
500000
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
19220
CY2014 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
193160
CY2014 us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2014 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
120000
CY2014 us-gaap Investment Income Interest
InvestmentIncomeInterest
7767
CY2014 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
500000
CY2014 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-12431413
CY2014 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
1200000
CY2014 us-gaap Interest Paid
InterestPaid
311991
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-12431413
CY2014 us-gaap Gain Loss On Non Recourse Debt
GainLossOnNonRecourseDebt
183944
CY2014 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
2084063
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-8112728
CY2014 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
348972
CY2014 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
500000
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-12431413
CY2014 us-gaap Stock Issued During Period Value Issued For Noncash Considerations
StockIssuedDuringPeriodValueIssuedForNoncashConsiderations
58518
CY2014 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
2459000
CY2014 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
2450000
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
928413
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
928413
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
11688604
CY2014 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3106678
CY2014 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3807320
CY2014 us-gaap Depreciation And Amortization
DepreciationAndAmortization
352429
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
4282441
CY2014 us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
193160
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Expected Dividend
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
CY2014 us-gaap Interest Expense Debt
InterestExpenseDebt
583076
CY2014 us-gaap Operating Expenses
OperatingExpenses
8112728
CY2014 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
3807320
CY2014 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
1200000
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2014 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
CY2014 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
50000
CY2014 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
120000
CY2014 us-gaap Interest Expense
InterestExpense
4510396
CY2014 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
13642667
CY2014 us-gaap Severance Costs1
SeveranceCosts1
172000
CY2014 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
3807000
CY2014 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
350000
CY2014 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-19220
CY2014 us-gaap Legal Fees
LegalFees
672153
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3981468
CY2014 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
176064
CY2014 cydy Deferred Debt Issuance Costs
DeferredDebtIssuanceCosts
120000
CY2014 cydy Preferred And Common Stock Subject To Rescission
PreferredAndCommonStockSubjectToRescission
158500
CY2014 cydy Stock Issued During Period Value Share Warrants Exercised
StockIssuedDuringPeriodValueShareWarrantsExercised
50000
CY2014 cydy Asset Purchase Agreement Aggregate Consideration Paying Period
AssetPurchaseAgreementAggregateConsiderationPayingPeriod
P10Y
CY2014 cydy Amortization Of Deferred Offering Cost Related To Rescission Liability
AmortizationOfDeferredOfferingCostRelatedToRescissionLiability
28636
CY2014 cydy Original Issue Discount And Intrinsic Value Of Beneficial Conversion Feature Related To Debt
OriginalIssueDiscountAndIntrinsicValueOfBeneficialConversionFeatureRelatedToDebt
1200000
CY2014 cydy Estimated Future Unvested Option Forfeitures
EstimatedFutureUnvestedOptionForfeitures
0.00 pure
CY2014 cydy Amortization Of Deferred Offering Costs Related To Rescission Liability
AmortizationOfDeferredOfferingCostsRelatedToRescissionLiability
28638
CY2014 cydy Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Exercised
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExercised
1.00
CY2014 cydy Issuance Of Common Stock In Private Stock Offering Value
IssuanceOfCommonStockInPrivateStockOfferingValue
13642667
CY2014 cydy Constructive Dividend To Preferred Stock Holders
ConstructiveDividendToPreferredStockHolders
6000000
CY2014 cydy Proceeds From Exercise Of Warrants And Stock Options
ProceedsFromExerciseOfWarrantsAndStockOptions
50000
CY2014 cydy Rescission Expirations And Exclusions
RescissionExpirationsAndExclusions
158500
CY2014 cydy Number Of Patent License Agreement
NumberOfPatentLicenseAgreement
3 Patent
CY2014 cydy Stock Issued During Period Value Warrant Exercised
StockIssuedDuringPeriodValueWarrantExercised
50000
CY2014 cydy Accounts Payable Extinguished Through Settlements
AccountsPayableExtinguishedThroughSettlements
183944
CY2014 cydy Warrants Granted Per Share
WarrantsGrantedPerShare
1.00
CY2014 cydy Issuance Of Common Stock In Private Stock Offering Unit
IssuanceOfCommonStockInPrivateStockOfferingUnit
1.30
CY2012 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y2M12D

Files In Submission

Name View Source Status
0001193125-14-265518-index-headers.html Edgar Link pending
0001193125-14-265518-index.html Edgar Link pending
0001193125-14-265518.txt Edgar Link pending
0001193125-14-265518-xbrl.zip Edgar Link pending
cydy-20140531.xml Edgar Link completed
cydy-20140531.xsd Edgar Link pending
cydy-20140531_cal.xml Edgar Link unprocessable
cydy-20140531_def.xml Edgar Link unprocessable
cydy-20140531_lab.xml Edgar Link unprocessable
cydy-20140531_pre.xml Edgar Link unprocessable
d735607d10k.htm Edgar Link pending
d735607dex1025.htm Edgar Link pending
d735607dex231.htm Edgar Link pending
d735607dex24.htm Edgar Link pending
d735607dex311.htm Edgar Link pending
d735607dex312.htm Edgar Link pending
d735607dex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending